Wang Si-Ying, Xia Zhi-Xuan, Yang Shao-Wei, Chen Wei-Kai, Zhao Yue-Ling, Li Meng-Die, Tian Dan, Pan Yue, Lin Xiao-Shan, Zhu Xiao-Qian, Huang Zhen, Liu Jian-Min, Lai Zhong-Meng, Tao Wu-Cheng, Shen Zu-Cheng
Department of Pharmacology, School of Pharmacy, Fujian Medical University, Fuzhou, China.
Department of Pharmacology, School of Basic Medicine and Life Science, Hainan Medical University, Haikou, China.
Br J Pharmacol. 2024 Jul;181(13):1897-1915. doi: 10.1111/bph.16318. Epub 2024 Feb 27.
Protein palmitoylation is involved in learning and memory, and in emotional disorders. Yet, the underlying mechanisms in these processes remain unclear. Herein, we describe that A-kinase anchoring protein 150 (AKAP150) is essential and sufficient for depressive-like behaviours in mice via a palmitoylation-dependent mechanism.
Depressive-like behaviours in mice were induced by chronic restraint stress (CRS) and chronic unpredictable mild stress (CUMS). Palmitoylated proteins in the basolateral amygdala (BLA) were assessed by an acyl-biotin exchange assay. Genetic and pharmacological approaches were used to investigate the role of the DHHC2-mediated AKAP150 palmitoylation signalling pathway in depressive-like behaviours. Electrophysiological recording, western blotting and co-immunoprecipitation were performed to define the mechanistic pathway.
Chronic stress successfully induced depressive-like behaviours in mice and enhanced AKAP150 palmitoylation in the BLA, and a palmitoylation inhibitor was enough to reverse these changes. Blocking the AKAP150-PKA interaction with the peptide Ht-31 abolished the CRS-induced AKAP150 palmitoylation signalling pathway. DHHC2 expression and palmitoylation levels were both increased after chronic stress. DHHC2 knockdown prevented CRS-induced depressive-like behaviours, as well as attenuating AKAP150 signalling and synaptic transmission in the BLA in CRS-treated mice.
These results delineate that DHHC2 modulates chronic stress-induced depressive-like behaviours and synaptic transmission in the BLA via the AKAP150 palmitoylation signalling pathway, and this pathway may be considered as a promising novel therapeutic target for major depressive disorder.
蛋白质棕榈酰化参与学习与记忆以及情绪障碍。然而,这些过程中的潜在机制仍不清楚。在此,我们描述A激酶锚定蛋白150(AKAP150)通过一种依赖棕榈酰化的机制对小鼠的抑郁样行为至关重要且具有充分作用。
通过慢性束缚应激(CRS)和慢性不可预测温和应激(CUMS)诱导小鼠的抑郁样行为。采用酰基生物素交换测定法评估基底外侧杏仁核(BLA)中的棕榈酰化蛋白。运用遗传和药理学方法研究DHHC2介导的AKAP150棕榈酰化信号通路在抑郁样行为中的作用。进行电生理记录、蛋白质免疫印迹和免疫共沉淀以确定作用机制途径。
慢性应激成功诱导小鼠出现抑郁样行为,并增强了BLA中AKAP150的棕榈酰化,一种棕榈酰化抑制剂足以逆转这些变化。用肽Ht - 31阻断AKAP150与PKA的相互作用消除了CRS诱导的AKAP150棕榈酰化信号通路。慢性应激后,DHHC2的表达和棕榈酰化水平均升高。敲低DHHC2可预防CRS诱导的抑郁样行为,同时减弱CRS处理小鼠BLA中的AKAP150信号传导和突触传递。
这些结果表明,DHHC2通过AKAP150棕榈酰化信号通路调节慢性应激诱导的抑郁样行为和BLA中的突触传递,该通路可能被视为重度抑郁症一个有前景的新型治疗靶点。